Solid lipid nanoparticles of amphotericin B (AmbiOnp): in vitro and in vivo assessment towards safe and effective oral treatment module

AmbiOnp: Solid Lipid Nanoparticles of Amphotericin B for Oral Administration

(2011) Pratikkumar A. Patel et al.   Journal of Biomedical Nanotechnology

A quantitative resazurin assay to determinate the viability of Trichomonas vaginalis and the cytotoxicity of organic solvents and surfactant agents

(2009) Mariana Duarte et al.   EXPERIMENTAL PARASITOLOGY

Highly Effective Oral Amphotericin B Formulation against Murine Visceral Leishmaniasis

(2009) Kishor M. Wasan et al.   JOURNAL OF INFECTIOUS DISEASES

Biodegradable Nanoparticles Improve Oral Bioavailability of Amphotericin B and Show Reduced Nephrotoxicity Compared to Intravenous Fungizone®

(2009) J. L. Italia et al.   PHARMACEUTICAL RESEARCH

Effect of aggregation state on the toxicity of different amphotericin B preparations

(2008) Raquel Espada et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Amphotericin B Formulations and Drug Targeting

(2007) J.J. Torrado et al.   JOURNAL OF PHARMACEUTICAL SCIENCES